Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Business
Anna Wise

AstraZeneca sales boosted by soaring demand for cancer treatments

AstraZeneca has reported a significant boost in sales for the first half of 2026, driven primarily by strong demand for its cancer and rare disease treatments, even as the pharmaceutical giant increased its investment in new research.

The Cambridge-based firm saw total revenues climb 6% at constant exchange rates to $30.67 billion (£22.99 billion).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.